{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:40:05Z","timestamp":1744972805303,"version":"3.40.4"},"publisher-location":"New York, NY","reference-count":44,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071644577"},{"type":"electronic","value":"9781071644584"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4458-4_8","type":"book-chapter","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T08:36:43Z","timestamp":1744965403000},"page":"79-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutralization Tests for Quantification of Specific Antibodies Against Yellow Fever Virus"],"prefix":"10.1007","author":[{"given":"Ana Carolina R. A.","family":"Cajaraville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/B978-1-4557-0090-5.00043-4","volume-title":"Vaccines","author":"T Monath","year":"2013","unstructured":"Monath T, Gershman M, Staples J, Barrett A (2013) Yellow fever vaccine. In: Plotkin S, Orenstein W, Offit P (eds) Vaccines, 6th edn. Saunders Elsevier, Philadelphia, pp 870\u2013968. Available from: http:\/\/www.sciencedirect.com\/science\/book\/9781455700905","edition":"6"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1749-6632.2001.tb02704.x","volume":"951","author":"JT Roehrig","year":"2001","unstructured":"Roehrig JT, Staudinger LA, Hunt AR, Mathews JH, Blair CD (2001) Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci 951:286\u2013297","journal-title":"Ann N Y Acad Sci"},{"key":"8_CR3","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000665","volume":"10","author":"TC Pierson","year":"2008","unstructured":"Pierson TC, Diamond MS (2008) Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med 10:e12","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"8_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0035-9203(54)90074-7","volume":"48","author":"JS Porterfield","year":"1954","unstructured":"Porterfield JS (1954) The haemagglutination-inhibition test in the diagnosis of yellow fever in man. Trans R Soc Trop Med Hyg 48(3):261\u2013266","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"8_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4269\/ajtmh.1958.7.585","volume":"7","author":"M Theiler","year":"1958","unstructured":"Theiler M, Casals J (1958) The serological reactions in yellow fever. Am J Trop Med Hyg 7(6):585\u2013594","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"8_CR6","first-page":"177","volume":"4","author":"JH Bauer","year":"1930","unstructured":"Bauer JH, Hudson NP (1930) The duration of immunity in human yellow fever as shown by the protective power of the serum. J Prev Med 4(3):177\u2013178","journal-title":"J Prev Med"},{"issue":"6","key":"8_CR7","first-page":"413","volume":"5","author":"WA Sawyer","year":"1931","unstructured":"Sawyer WA (1931) The persistence of yellow fever immunity. J Prev Med 5(6):413\u2013428","journal-title":"J Prev Med"},{"issue":"3","key":"8_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","volume":"4","author":"TC Pierson","year":"2008","unstructured":"Pierson TC, Fremont DH, Kuhn RJ, Diamond MS (2008) Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4(3):229\u2013238","journal-title":"Cell Host Microbe"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"TP Monath","year":"2015","unstructured":"Monath TP, Vasconcelos PFC (2015) Yellow fever. J Clin Virol 64:160\u2013173","journal-title":"J Clin Virol"},{"issue":"11","key":"8_CR10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","volume":"17","author":"FM Shearer","year":"2017","unstructured":"Shearer FM, Moyes CL, Pigott DM, Brady OJ, Marinho F, Deshpande A et al (2017) Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis. Lancet Infect Dis 17(11):1209\u20131217","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"8_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/viro.1999.9887","volume":"263","author":"J An","year":"1999","unstructured":"An J, Kimura-Kuroda J, Hirabayashi Y, Yasui K (1999) Development of a novel mouse model for dengue virus infection. Virology 263(1):70\u201377","journal-title":"Virology"},{"issue":"9","key":"8_CR12","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K et al (2004) Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol 78(9):4761\u20134775","journal-title":"J Virol"},{"issue":"35","key":"8_CR13","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1016\/j.vaccine.2005.03.042","volume":"23","author":"J Robert Putnak","year":"2005","unstructured":"Robert Putnak J, Coller B-A, Voss G, Vaughn DW, Clements D, Peters I et al (2005) An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine 23(35):4442\u20134452","journal-title":"Vaccine"},{"issue":"2","key":"8_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/vim.2008.0007","volume":"21","author":"JT Roehrig","year":"2008","unstructured":"Roehrig JT, Hombach J, Barrett ADT (2008) Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol 21(2):123\u2013132","journal-title":"Viral Immunol"},{"issue":"39","key":"8_CR15","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","volume":"32","author":"Collaborative Group for Studies on Yellow Fever Vaccines","year":"2014","unstructured":"Collaborative Group for Studies on Yellow Fever Vaccines (2014) Duration of post-vaccination immunity against yellow fever in adults. Vaccine 32(39):4977\u20134984","journal-title":"Vaccine"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","volume":"59","author":"JT Roehrig","year":"2003","unstructured":"Roehrig JT (2003) Antigenic structure of flavivirus proteins. Adv Virus Res 59:141\u2013175","journal-title":"Adv Virus Res"},{"issue":"9","key":"8_CR17","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","volume":"83","author":"PJ Klasse","year":"2002","unstructured":"Klasse PJ, Sattentau QJ (2002) Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J Gen Virol 83(9):2091\u20132108","journal-title":"J Gen Virol"},{"issue":"4","key":"8_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jmv.1890450417","volume":"45","author":"RT He","year":"1995","unstructured":"He RT, Innis BL, Nisalak A, Usawattanakul W, Wang S, Kalayanarooj S et al (1995) Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol 45(4):451\u2013461","journal-title":"J Med Virol"},{"issue":"2","key":"8_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1099\/vir.0.80411-0","volume":"86","author":"JJH Chu","year":"2005","unstructured":"Chu JJH, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng M-L (2005) Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 86(2):405\u2013412","journal-title":"J Gen Virol"},{"issue":"6067","key":"8_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/321244a0","volume":"321","author":"SW Gollins","year":"1986","unstructured":"Gollins SW, Porterfield JS (1986) A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321(6067):244\u2013246","journal-title":"Nature"},{"issue":"1","key":"8_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016059","volume":"6","author":"Y-Q Deng","year":"2011","unstructured":"Deng Y-Q, Dai J-X, Ji G-H, Jiang T, Wang H-J, Yang H et al (2011) A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One 6(1):e16059","journal-title":"PLoS One"},{"issue":"33","key":"8_CR22","doi-asserted-by":"publisher","first-page":"12400","DOI":"10.1073\/pnas.0603488103","volume":"103","author":"B Kaufmann","year":"2006","unstructured":"Kaufmann B, Nybakken GE, Chipman PR, Zhang W, Diamond MS, Fremont DH et al (2006) West Nile virus in complex with the fab fragment of a neutralizing monoclonal antibody. Proc Natl Acad Sci USA 103(33):12400\u201312404","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"8_CR23","doi-asserted-by":"publisher","first-page":"11467","DOI":"10.1128\/JVI.01125-06","volume":"80","author":"GE Nybakken","year":"2006","unstructured":"Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH (2006) Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80(23):11467\u201311474","journal-title":"J Virol"},{"key":"8_CR24","unstructured":"World Health Organization (2008) Investigation of yellow fever epidemics in Africa. FIELD GUIDE. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/69874\/WHO_HSE_EPR_2008.5_eng.pdf?sequence=1"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1590\/S1415-790X2002000300004","volume":"5","author":"PFC Vasconcelos","year":"2002","unstructured":"Vasconcelos PFC (2002) Febre amarela: reflex\u00f5es sobre a doen\u00e7a, as perspectivas para o s\u00e9culo XXI e o risco da reurbaniza\u00e7\u00e3o. Rev Bras Epidemiol 5:244\u2013258","journal-title":"Rev Bras Epidemiol"},{"issue":"12","key":"8_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S1286-4579(02)01647-7","volume":"4","author":"P Koraka","year":"2002","unstructured":"Koraka P, Zeller H, Niedrig M, Osterhaus ADME, Groen J (2002) Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 4(12):1209\u20131215","journal-title":"Microbes Infect"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0035-9203(59)90021-5","volume":"53","author":"JS Porterfield","year":"1959","unstructured":"Porterfield JS (1959) A plaque technique for the titration of yellow fever virus and antisera. Trans R Soc Trop Med Hyg 53:458\u2013466","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"8_CR28","first-page":"113","volume":"40","author":"AT De Madrid","year":"1969","unstructured":"De Madrid AT, Porterfield JS (1969) A simple micro-culture method for the study of group B arboviruses. Bull World Health Organ 40(1):113\u2013121","journal-title":"Bull World Health Organ"},{"issue":"12","key":"8_CR29","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","volume":"4","author":"M Niedrig","year":"1999","unstructured":"Niedrig M, Lademann M, Emmerich P, Lafrenz M (1999) Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 4(12):867\u2013871","journal-title":"Trop Med Int Health"},{"issue":"52","key":"8_CR30","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1016\/j.vaccine.2010.10.070","volume":"28","author":"M Ferguson","year":"2010","unstructured":"Ferguson M, Shin J, Knezevic I, Minor P, Barrett A (2010) WHO working group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13\u201314 May 2009. Vaccine 28(52):8236\u20138245","journal-title":"Vaccine"},{"issue":"1","key":"8_CR31","first-page":"33","volume":"195","author":"A Maeda","year":"2013","unstructured":"Maeda A, Maeda J (2013) Review of diagnostic plaque reduction neutralization tests for flavivirus infection. Vet J Lond Engl 195(1):33\u201340","journal-title":"Vet J Lond Engl"},{"issue":"2","key":"8_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/CVI.00078-07","volume":"15","author":"M Niedrig","year":"2008","unstructured":"Niedrig M, K\u00fcrsteiner O, Herzog C, Sonnenberg K (2008) Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus. Clin Vaccine Immunol 15(2):177\u2013181","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"8_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1084\/jem.54.4.533","volume":"54","author":"WA Sawyer","year":"1931","unstructured":"Sawyer WA, Lloyd W (1931) The use of mice in tests of immunity against yellow fever. J Exp Med 54(4):533\u2013555","journal-title":"J Exp Med"},{"issue":"1","key":"8_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.1943.s1-23.17","volume":"s1-23","author":"L Whitman","year":"1943","unstructured":"Whitman L (1943) A modified intraperitoneal protection test for yellow fever based on the greater susceptibility of immature white mice to the extraneural injection of yellow fever virus. Am J Trop Med Hyg s1-23(1):17\u201336","journal-title":"Am J Trop Med Hyg"},{"key":"8_CR35","first-page":"83","volume-title":"Introdu\u00e7\u00e3o \u00e0 virologia humana","author":"N Santos","year":"2008","unstructured":"Santos N, Benati F (2008) Diagn\u00f3stico laboratorial das viroses. In: Santos N, Romanos M, Wigg M (eds) Introdu\u00e7\u00e3o \u00e0 virologia humana, 2th edn. Guanabara Koogan S.A, Rio de Janeiro, pp 83\u2013116","edition":"2"},{"key":"8_CR36","unstructured":"World Health Organization (2014) World \u2013 yellow fever vaccination booster. WHO \u2013 international travel and health. Available from: http:\/\/www.who.int\/ith\/updates\/20140605\/en\/"},{"issue":"3","key":"8_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","volume":"89","author":"E Gotuzzo","year":"2013","unstructured":"Gotuzzo E, Yactayo S, C\u00f3rdova E (2013) Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg 89(3):434\u2013444","journal-title":"Am J Trop Med Hyg"},{"issue":"35","key":"8_CR38","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1016\/j.vaccine.2015.03.077","volume":"33","author":"RC Pereira","year":"2015","unstructured":"Pereira RC, Silva AN, Souza MCO, Silva MV, Neves PP et al (2015) An inactivated yellow fever 17DD vaccine cultivated in vero cell cultures. Vaccine 33(35):4261\u20134268","journal-title":"Vaccine"},{"issue":"2","key":"8_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4269\/ajtmh.16-0293","volume":"98","author":"S Tottey","year":"2018","unstructured":"Tottey S, Shoji Y, Jones RM, Chichester JA, Green BJ, Musiychuk K et al (2018) Plant-produced subunit vaccine candidates against yellow fever induce virus neutralizing antibodies and confer protection against viral challenge in animal models. Am J Trop Med Hyg 98(2):420\u2013431","journal-title":"Am J Trop Med Hyg"},{"key":"8_CR40","first-page":"1","volume":"980","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014) WHO expert committee on biological standardization. Sixty-third report. World Health Organ Tech Rep Ser 980:1\u2013489","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"8_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4269\/ajtmh.2008.79.115","volume":"79","author":"JR Putnak","year":"2008","unstructured":"Putnak JR, de la Barrera R, Burgess T, Pardo J, Dessy F, Gheysen D et al (2008) Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies. Am J Trop Med Hyg 79(1):115\u2013122","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"8_CR42","first-page":"796","volume":"10","author":"SY G\u00f3mez","year":"2008","unstructured":"G\u00f3mez SY, Ocazionez RE (2008) Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue. Rev Salud Publica Bogota Colomb 10(5):796\u2013807","journal-title":"Rev Salud Publica Bogota Colomb"},{"issue":"4","key":"8_CR43","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4161\/hv.22982","volume":"9","author":"RM Martins","year":"2013","unstructured":"Martins RM et al (2013) 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum Vaccin Immunother 9(4):879\u2013888","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"8_CR44","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","volume":"88","author":"TM Timiryasova","year":"2013","unstructured":"Timiryasova TM, Bonaparte MI, Luo P, Zedar R, Hu BT, Hildreth SW (2013) Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development. Am J Trop Med Hyg 88(5):962\u2013970","journal-title":"Am J Trop Med Hyg"}],"container-title":["Methods in Molecular Biology","Yellow Fever Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4458-4_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:02:13Z","timestamp":1744970533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4458-4_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644577","9781071644584"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4458-4_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"19 April 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}